Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Bone Loss, Perimenopausal

cetylpyridinium chloride anhydrous has been researched along with Bone Loss, Perimenopausal in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (33.33)29.6817
2010's6 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gunn, CA; Kruger, MC; Weber, JL1
Havemann-Nel, L; Kruger, A; Kruger, HS; Kruger, IM; Sotunde, OF; Tieland, M; Wentzel-Viljoen, E; Wright, HH1
Gostout, BS; Grossardt, BR; Rhodes, DJ; Rocca, WA; Shuster, LT1
Bhasin, S; Blackman, MR; Cappola, AR; Cauley, JA; Harris, TB; Rariy, CM; Ratcliffe, SJ; Robbins, J; Weinstein, R; Zmuda, JM1
Eiken, P; Jensen, JE; Køber, L; Mosekilde, L; Rejnmark, L; Schierbeck, LL; Stilgren, L; Tofteng, CL1
Butz, H; Feldman, K; Grolmusz, V; Kriszt, B; Lakatos, P; Likó, I; Majnik, J; Patócs, A; Rácz, K; Szappanos, A; Tóth, M1
Alexandersen, P; Azria, M; Bagger, YZ; Benmammar, H; Chick, R; Christiansen, C; Devogelaer, JP; Mindeholm, L; Olson, M; Reginster, JY; Tankó, LB1
Reinwald, S; Weaver, CM1
Charney, P; Cramer, DA; Dolan, NC; Gillock, MR; Kefalides, PT; Walsh, JM1

Reviews

3 review(s) available for cetylpyridinium chloride anhydrous and Bone Loss, Perimenopausal

ArticleYear
Premature menopause or early menopause: long-term health consequences.
    Maturitas, 2010, Volume: 65, Issue:2

    Topics: Adult; Cardiovascular Diseases; Dementia; Female; Health; Humans; Menopause, Premature; Middle Aged; Osteoporosis, Postmenopausal; Risk Factors

2010
Soy isoflavones and bone health: a double-edged sword?
    Journal of natural products, 2006, Volume: 69, Issue:3

    Topics: Animals; Bone and Bones; Bone Diseases; Female; Health; Humans; Isoflavones; Menopause; Osteoporosis, Postmenopausal; Phytoestrogens; Rats; Receptors, Estrogen; Soy Foods; United States

2006
Update in women's health.
    Annals of internal medicine, 2000, Nov-21, Volume: 133, Issue:10

    Topics: Breast Neoplasms; Contraceptives, Oral; Coronary Disease; Domestic Violence; Female; Health; Hormone Replacement Therapy; Humans; Male; Obesity; Osteoporosis, Postmenopausal; Sexual Dysfunction, Physiological; United States; Women

2000

Trials

1 trial(s) available for cetylpyridinium chloride anhydrous and Bone Loss, Perimenopausal

ArticleYear
Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2004, Volume: 19, Issue:9

    Topics: Administration, Oral; Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Bone Remodeling; Calcitonin; Calcium; Dose-Response Relationship, Drug; Double-Blind Method; Female; Health; Humans; Middle Aged; Osteoporosis, Postmenopausal; Parathyroid Hormone; Postmenopause; Time Factors

2004

Other Studies

5 other study(ies) available for cetylpyridinium chloride anhydrous and Bone Loss, Perimenopausal

ArticleYear
Diet, weight, cytokines and bone health in postmenopausal women.
    The journal of nutrition, health & aging, 2014, Volume: 18, Issue:5

    Topics: Absorptiometry, Photon; Aged; Body Composition; Body Mass Index; Body Weight; Bone Density; Bone Diseases, Metabolic; C-Reactive Protein; Collagen Type I; Cross-Sectional Studies; Cytokines; Dairy Products; Diet; Dietary Proteins; Female; Health; Humans; Inflammation; Interleukin-10; Interleukin-6; Middle Aged; New Zealand; Osteoporosis, Postmenopausal; Osteoprotegerin; Peptide Fragments; Peptides; Postmenopause; Potassium; Procollagen; Tumor Necrosis Factor-alpha; Vitamin B 12; Zinc

2014
Lean Mass Appears to Be More Strongly Associated with Bone Health than Fat Mass in Urban Black South African Women.
    The journal of nutrition, health & aging, 2015, Volume: 19, Issue:6

    Topics: Absorptiometry, Photon; Adiposity; Adult; Black People; Body Mass Index; Body Weight; Bone and Bones; Bone Density; Calcium; Cross-Sectional Studies; Diet; Energy Metabolism; Female; Femur Neck; Fractures, Bone; Health; Humans; Life Style; Middle Aged; Motor Activity; Osteoporosis, Postmenopausal; Pelvic Bones; Postmenopause; Risk Assessment; South Africa; Spine; Surveys and Questionnaires; Thinness; Urban Population

2015
Higher serum free testosterone concentration in older women is associated with greater bone mineral density, lean body mass, and total fat mass: the cardiovascular health study.
    The Journal of clinical endocrinology and metabolism, 2011, Volume: 96, Issue:4

    Topics: Adipose Tissue; Aged; Aged, 80 and over; Body Mass Index; Bone Density; Cardiovascular Physiological Phenomena; Cohort Studies; Female; Health; Humans; Organ Size; Osmolar Concentration; Osteoporosis, Postmenopausal; Testosterone; Thinness; Up-Regulation

2011
Vitamin D deficiency in postmenopausal, healthy women predicts increased cardiovascular events: a 16-year follow-up study.
    European journal of endocrinology, 2012, Volume: 167, Issue:4

    Topics: Cardiovascular Diseases; Clinical Trials as Topic; Estrogen Replacement Therapy; Female; Follow-Up Studies; Health; Humans; Middle Aged; Osteoporosis, Postmenopausal; Postmenopause; Prognosis; Risk Factors; Survival Analysis; Time Factors; Vitamin D; Vitamin D Deficiency

2012
The rs4844880 polymorphism in the promoter region of the HSD11B1 gene associates with bone mineral density in healthy and postmenopausal osteoporotic women.
    Steroids, 2012, Volume: 77, Issue:13

    Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 1; Adult; Aged; Aged, 80 and over; Biomarkers; Bone and Bones; Bone Density; Case-Control Studies; Female; Gene Frequency; Genotype; Health; Humans; Middle Aged; Osteoporosis, Postmenopausal; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Young Adult

2012